BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31456223)

  • 1. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
    van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.
    Melo P; Georgiou EX; Johnson N; van Voorst SF; Strandell A; Mol BWJ; Becker C; Granne IE
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002125. PubMed ID: 33091963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical approach to hysterectomy for benign gynaecological disease.
    Pickett CM; Seeratan DD; Mol BWJ; Nieboer TE; Johnson N; Bonestroo T; Aarts JW
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD003677. PubMed ID: 37642285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis for elective hysterectomy.
    Ayeleke RO; Mourad S; Marjoribanks J; Calis KA; Jordan V
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD004637. PubMed ID: 28625021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrier agents for adhesion prevention after gynaecological surgery.
    Ahmad G; Kim K; Thompson M; Agarwal P; O'Flynn H; Hindocha A; Watson A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD000475. PubMed ID: 32199406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical approach to hysterectomy for benign gynaecological disease.
    Aarts JW; Nieboer TE; Johnson N; Tavender E; Garry R; Mol BW; Kluivers KB
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD003677. PubMed ID: 26264829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to reduce shoulder pain following gynaecological laparoscopic procedures.
    Kaloo P; Armstrong S; Kaloo C; Jordan V
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011101. PubMed ID: 30699235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrier agents for adhesion prevention after gynaecological surgery.
    Ahmad G; O'Flynn H; Hindocha A; Watson A
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD000475. PubMed ID: 25924805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robot-assisted surgery in gynaecology.
    Liu H; Lawrie TA; Lu D; Song H; Wang L; Shi G
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD011422. PubMed ID: 25493418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robot-assisted surgery in gynaecology.
    Lawrie TA; Liu H; Lu D; Dowswell T; Song H; Wang L; Shi G
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011422. PubMed ID: 30985921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial.
    Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ; Kwon SH
    BJOG; 2017 Jan; 124(2):314-320. PubMed ID: 27342222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing surgical outcome and ovarian reserve after laparoscopic hysterectomy between two methods of with and without prophylactic bilateral salpingectomy: A randomized controlled trial.
    Asgari Z; Tehranian A; Rouholamin S; Hosseini R; Sepidarkish M; Rezainejad M
    J Cancer Res Ther; 2018; 14(3):543-548. PubMed ID: 29893313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery.
    Ahmad G; Thompson M; Kim K; Agarwal P; Mackie FL; Dias S; Metwally M; Watson A
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD001298. PubMed ID: 32683695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
    Collins E; Strandell A; Granåsen G; Idahl A
    Am J Obstet Gynecol; 2019 Jan; 220(1):85.e1-85.e10. PubMed ID: 30321526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Fergusson RJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD000329. PubMed ID: 33619722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for endometrial hyperplasia.
    Clement NS; Oliver TR; Shiwani H; Sanner JR; Mulvaney CA; Atiomo W
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012214. PubMed ID: 29077194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.